In the present work, we examine whether meridianins are capable to inhibit neural GSK3β in vivo and if such inhibition induces improvements in the 5xFAD mouse model of Alzheimer’s Disease. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.